Andere Kunden interessierten sich auch für
![CMV infections in kidney transplant patients]( "CMV infections in kidney transplant patients")
CMV infections in kidney transplant patients29,99 €![Skin grafting for donor site wounds in elderly patients]( "Skin grafting for donor site wounds in elderly patients")
Skin grafting for donor site wounds in elderly patients16,99 €![Viral infections in renal transplant patients]( "Viral infections in renal transplant patients")
Viral infections in renal transplant patients29,99 €![Impact of MIDCAB grafting on early postoperative renal function]( "Impact of MIDCAB grafting on early postoperative renal function")
Impact of MIDCAB grafting on early postoperative renal function24,99 €![The Story of the First Kidney Transplant in Guyana, South America]( "The Story of the First Kidney Transplant in Guyana, South America")
The Story of the First Kidney Transplant in Guyana, South America15,99 €![Task oriented intervention in post stroke patients]( "Task oriented intervention in post stroke patients")
Task oriented intervention in post stroke patients29,99 €![A process for melt grafting itaconic anhydride onto polyethylene]( "A process for melt grafting itaconic anhydride onto polyethylene")
A process for melt grafting itaconic anhydride onto polyethylene32,99 €
POST-GRAFTING HEALTHCARE AFTER KIDNEY TRANSPLANT It is now well established that early kidney transplantation is associated with optimal outcomes in terms of patient and graft survival. In chronic kidney disease (CKD) - Stage V patients, kidney transplantation is considered as the treatment of choice because both survival and quality of life are often better than in people who are treated with dialysis. After kidney transplantation, patients receive a combination of immunosuppressive medications to prevent rejection of the transplanted kidney. Newer immunosuppressive drug regimens have resulted in improving the outcomes in kidney transplantation in the last two decades. These regimens usually contain a (CNI) calcineurin-inhibitor (tacrolimus or cyclosporine), steroids along with antiproliferative agent mycophenolate mofetil (MMF).The introduction of azathioprine as an effective oral immunosuppressant in the late 1950s resulted in achieving the first long-term survivors of transplants between genetically non-identical individuals (allografts). This drug acts by inhibiting purine synthesis.